Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis

  • Authors:
    • Yuechong Cui
    • Bin Zhu
    • Fei Zheng
  • View Affiliations / Copyright

    Affiliations: Department of Human Health and Human Services, Yiwu Maternity and Children Health Care Hospital, Yiwu, Zhejiang 322000, P.R. China, Department of Obstetrics and Gynecology, Yiwu Maternity and Children Health Care Hospital, Yiwu, Zhejiang 322000, P.R. China
    Copyright: © Cui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4361-4369
    |
    Published online on: March 20, 2018
       https://doi.org/10.3892/etm.2018.5972
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present meta-analysis study was to evaluate the efficacy of low‑dose aspirin, commenced at ≤16 weeks of gestation, in preventing preterm and term preeclampsia, as well as associated maternal and neonatal adverse events in women at risk of preeclampsia. The Embase, PubMed, Cochrane Central Register of Controlled Trials and the Web of Science databases were searched for relevant random controlled trials (RCTs) published between January 1979 and October 2017. After quality assessment and data extraction, a meta‑analysis was performed using RevMan 5.3 software. Outcomes of interest were preeclampsia with subgroups of preterm preeclampsia (delivery at <37 weeks) and term preeclampsia, as well as maternal adverse outcomes, including gestational hypertension, postpartum hemorrhage and preterm birth, and neonatal adverse outcomes, including intrauterine growth retardation (IUGR) or small for gestation age infant (SGA), stillbirth or death, and newborn weight. A total of 10 RCTs involving 3,168 participants were included. The meta‑analysis demonstrated that, compared with placebo or no treatment, low‑dose aspirin was associated with a significant reduction in the overall risk ratio (RR) of preeclampsia regardless of the time to delivery [RR=0.67; 95% confidence interval (CI)=0.57‑0.80]. This was apparent for preterm preeclampsia (RR=0.35; 95% CI=0.13‑0.94) but not for term preeclampsia (RR=1.01; 95% CI=0.60‑1.70). Except for postpartum hemorrhage, low‑dose aspirin also significantly reduced the risk of maternal and neonatal adverse outcomes. In conclusion, low‑dose aspirin in women at risk of preeclampsia, commenced at ≤16 weeks of gestation, was associated with a reduced risk of preterm preeclampsia, and of adverse maternal and neonatal outcomes.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Steegers EA, von Dadelszen P, Duvekot JJ and Pijnenborg R: Pre-eclampsia. Lancet. 376:631–644. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Tooher J, Thornton C, Makris A, Ogle R, Korda A, Horvath J and Hennessy A: Hypertension in pregnancy and long-term cardiovascular mortality: A retrospective cohort study. Am J Obstet Gynecol. 214:722.e1–6. 2016. View Article : Google Scholar

3 

Crandon AJ and Isherwood DM: Effect of aspirin on incidence of pre-eclampsia. Lancet. 1:13561979. View Article : Google Scholar : PubMed/NCBI

4 

Askie LM, Duley L, Hendersonsmart DJ and Stewart LA: PARIS Collaborative Group: Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet. 369:1791–1798. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Groeneveld E, Lambers MJ, Lambalk CB, Broeze KA, Haapsamo M, de Sutter P, Schoot BC, Schats R, Mol BW and Hompes PG: Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: A meta-analysis with individual patient data. Hum Reprod. 28:1480–1488. 2013. View Article : Google Scholar : PubMed/NCBI

6 

CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of pre eclampsia among 9364 pregnant-women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 343:619–629. 1994. View Article : Google Scholar : PubMed/NCBI

7 

Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al: Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 377:613–622. 2017. View Article : Google Scholar : PubMed/NCBI

8 

World Health Organization (WHO): WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. WHO; Geneva: 2011

9 

Moher D, Liberati A, Tetzlaff J and Altman DG: PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 6:e10000972009. View Article : Google Scholar : PubMed/NCBI

10 

Green S: Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Wiley-Blackwell; 2008, View Article : Google Scholar

11 

Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N and Bujold E: The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis. Am J Obstet Gynecol. 216:110–120.e6. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Roberge S, Nicolaides KH, Demers S, Villa P and Bujold E: Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A meta-analysis. Ultrasound Obstet Gynecol. 41:491–499. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Henderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH and Rowland MG: Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. preventive services task force. Ann Intern Med. 160:695–703. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Roberge S, Sibai B, McCaw-Binns A and Bujold E: Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: Meta-analysis of large randomized trials. Am J Perinatol. 33:781–785. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Bergeron TS, Roberge S, Carpentier C, Sibai B, Mccaw-Binns A and Bujold E: Prevention of preeclampsia with aspirin in multiple gestations: A systematic review and meta-analysis. Am J Perinatol. 33:605–610. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Meher S and Alfirevic Z: Aspirin for pre-eclampsia: Beware of subgroup meta-analysis. Ultrasound Obstet Gynecol. 41:479–485. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Abalos E, Duley L, Steyn DW and Henderson-Smart DJ: Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev: Cd002252. 2007. View Article : Google Scholar

18 

Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG, Bild DE, et al: Trial of calcium to prevent preeclampsia. N Engl J Med. 337:69–76. 1997. View Article : Google Scholar : PubMed/NCBI

19 

Conde-Agudelo A, Romero R, Kusanovic JP and Hassan SS: Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 204:503.e1–12. 2011. View Article : Google Scholar

20 

Costantine MM, Cleary K, Hebert MF, Ahmed MS, Brown LM, Ren Z, Easterling TR, Haas DM, Haneline LS, Caritis SN, et al: Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am J Obstet Gynecol. 214:720.e1–720.e17. 2016. View Article : Google Scholar

21 

Knöfler M and Pollheimer J: IFPA award in placentology lecture: Molecular regulation of human trophoblast invasion. Placenta. 33 Suppl:S55–S62. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Quyyumi AA: Effects of aspirin on endothelial dysfunction in atherosclerosis. Am J Cardiol. 82:31S–33S. 1998. View Article : Google Scholar : PubMed/NCBI

23 

Tarim E, Bal N, Kilicdag E, Kayaselcuk F, Bağiş T and Kuscu E: Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history. Arch Gynecol Obstet. 274:209–214. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC and Giguère Y: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol. 116:402–414. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Meher S, Duley L, Hunter K and Askie L: Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol. 216:121–128.e2. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Borenstein M, Hedges LV, Higgins JPT and Rothstein HR: Introduction to meta-analysis. John Wiley & Sons; Hoboken, NJ: 2009, View Article : Google Scholar

27 

Ayala DE, Ucieda R and Hermida RC: Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 30:260–279. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Bakhti A and Vaiman D: Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertens Res. 34:1116–1120. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R, et al: Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med. 321:357–362. 1989. View Article : Google Scholar : PubMed/NCBI

30 

Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, et al: Low-dose aspirin to prevent preeclampsia in women at high risk National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 338:701–705. 1998. View Article : Google Scholar : PubMed/NCBI

31 

Chiaffarino F, Parazzini F, Paladini D, Acaia B, Ossola W, Marozio L, Facchinetti F and Del Giudice A: A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 112:142–144. 2004. View Article : Google Scholar : PubMed/NCBI

32 

Ebrashy A, Ibrahim M, Marzook A and Yousef D: Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14–16 weeks pregnancy: Randomized controlled clinical trial. Croat Med J. 46:826–831. 2005.PubMed/NCBI

33 

Hermida RC, Ayala DE, Iglesias M, Mojón A, Silva I, Ucieda R and Fernández JR: Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension. 30:589–595. 1997. View Article : Google Scholar : PubMed/NCBI

34 

Vainio M, Kujansuu E, Iso-Mustajärvi M and Mäenpää J: Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG. 109:161–167. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Villa PM, Kajantie E, Räikkönen K, Pesonen AK, Hämäläinen E, Vainio M, Taipale P and Laivuori H: PREDO Study group: Aspirin in the prevention of pre-eclampsia in high-risk women: A randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG. 120:64–74. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cui Y, Zhu B and Zheng F: Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis. Exp Ther Med 15: 4361-4369, 2018.
APA
Cui, Y., Zhu, B., & Zheng, F. (2018). Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis. Experimental and Therapeutic Medicine, 15, 4361-4369. https://doi.org/10.3892/etm.2018.5972
MLA
Cui, Y., Zhu, B., Zheng, F."Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis". Experimental and Therapeutic Medicine 15.5 (2018): 4361-4369.
Chicago
Cui, Y., Zhu, B., Zheng, F."Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis". Experimental and Therapeutic Medicine 15, no. 5 (2018): 4361-4369. https://doi.org/10.3892/etm.2018.5972
Copy and paste a formatted citation
x
Spandidos Publications style
Cui Y, Zhu B and Zheng F: Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis. Exp Ther Med 15: 4361-4369, 2018.
APA
Cui, Y., Zhu, B., & Zheng, F. (2018). Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis. Experimental and Therapeutic Medicine, 15, 4361-4369. https://doi.org/10.3892/etm.2018.5972
MLA
Cui, Y., Zhu, B., Zheng, F."Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis". Experimental and Therapeutic Medicine 15.5 (2018): 4361-4369.
Chicago
Cui, Y., Zhu, B., Zheng, F."Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis". Experimental and Therapeutic Medicine 15, no. 5 (2018): 4361-4369. https://doi.org/10.3892/etm.2018.5972
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team